Precursor Condition
Cervical Intraepithelial Neoplasia
CI-CAN-00000664CINExplore in graph →
Precursor45 active trials
Loading cancer entity…
Loading cancer entity…
Precursor Condition
CI-CAN-00000664CINExplore in graph →
Clinical trials
316 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01511328 | Randomized Implementation of Primary HPV Testing in the Organized Screening for Cervical Cancer in Stockholm | active not recruiting | N/A | 270,000 | Karolinska InstitutetOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT02864147 | Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3) | completed | Phase 2 | 134 | Yale UniversityOTHER | 1 | May 2, 2024 | clinicaltrials |
| NCT04751799 |
| Virtual Reality: Influence on Satisfaction, Pain, and Anxiety in Patients Undergoing Colposcopy |
| completed |
| N/A |
| 247 |
| Ruhr University of BochumOTHER |
| 1 |
| Apr 26, 2024 |
| clinicaltrials |
| NCT04895020 | Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years | unknown | Phase 3 | 1,200 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Apr 17, 2024 | clinicaltrials |
| NCT03285841 | OCT-AF Imaging of Pre-cancers of Vulva and Cervix | terminated | — | 20 | British Columbia Cancer AgencyOTHER | 1 | Mar 18, 2024 | clinicaltrials |
| NCT03629886 | Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study | completed | Phase 4 | 6,051 | GlaxoSmithKlineINDUSTRY | 1 | Mar 15, 2024 | clinicaltrials |
| NCT06314113 | Evaluation of Oral EGCG Treatment for L-SIL Associated With HPV Infection(EGCG-HPV) | unknown | — | 50 | University of PalermoOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT01865929 | Minimally Invasive Benign Hysterectomy | completed | N/A | 124 | Region SkaneOTHER | 1 | Mar 4, 2024 | clinicaltrials |
| NCT05234112 | Prevention and Screening Towards Elimination of Cervical Cancer(PRESCRIP-TEC) | completed | N/A | 30,000 | University Medical Center GroningenOTHER | 1 | Feb 22, 2024 | clinicaltrials |
| NCT06273553 | A Study in Subjects With Human Papillomavirus 16 or 18 Associated Cervical Intraepithelial Neoplasia Grade 2 or 3 | not yet recruiting | Phase 1 / Phase 2 | 39 | RinuaGene Biotechnology Co., Ltd.INDUSTRY | 0 | Feb 22, 2024 | clinicaltrials |
| NCT06261879 | Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer--ACTN4 and Other Biomarkers in Menstrual Blood | unknown | N/A | 300 | WomenX Biotech LimitedINDUSTRY | 1 | Feb 15, 2024 | clinicaltrials |
| NCT05613283 | Primary Cervical Cancer Screening by Self-sampling HPV Test(PREVENT) | active not recruiting | — | 17,875 | Peking University People's HospitalOTHER | 1 | Dec 21, 2023 | clinicaltrials |
| NCT02481414 | A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions | completed | Phase 2 | 81 | University of ArkansasOTHER | 1 | Dec 18, 2023 | clinicaltrials |
| NCT04679675 | Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial(STEP) | completed | N/A | 32,771 | Kaiser PermanenteOTHER | 1 | Sep 18, 2023 | clinicaltrials |
| NCT05405270 | Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment(PRedICT-TOPIC) | recruiting | — | 410 | Catharina Ziekenhuis EindhovenOTHER | 1 | Sep 11, 2023 | clinicaltrials |
| NCT06015854 | Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II(Vvax) | unknown | Phase 2 | 18 | University Medical Center GroningenOTHER | 1 | Aug 29, 2023 | clinicaltrials |
| NCT05996796 | Dry Run of the ScreenUrSelf Trial | completed | N/A | 38 | Universiteit AntwerpenOTHER | 1 | Aug 18, 2023 | clinicaltrials |
| NCT03185013 | REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)(REVEAL 1) | completed | Phase 3 | 201 | Inovio PharmaceuticalsINDUSTRY | 19 | Jul 27, 2023 | clinicaltrials |
| NCT05120167 | Strategies for Endocervical Canal Investigation in Women With Abnormal Screening Cytology and Negative Colposcopy | completed | N/A | 288 | Cirbia Silva Campos TeixeiraOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05756192 | Educational Video's Impact on Knowledge Regarding Cervical Cancer Screening | completed | N/A | 200 | George Washington UniversityOTHER | 1 | Jul 11, 2023 | clinicaltrials |
| NCT05931354 | Longitudinal HPV Pap in CIN and VAIN(LHPCV) | unknown | — | 600 | Chang Gung Memorial HospitalOTHER | 1 | Jul 5, 2023 | clinicaltrials |
| NCT03763565 | Effectiveness of HPV Vaccine in Thai Adult Women | completed | — | 993 | Mahidol UniversityOTHER | 1 | Jun 5, 2023 | clinicaltrials |
| NCT05851079 | Accurate Screening and Prevention of Cervical Lesions-- Development of Accurate Screening Methods for Cervical Lesions | unknown | — | 15,000 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 1 | May 9, 2023 | clinicaltrials |
| NCT02740777 | Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females | completed | Phase 2 | 900 | Shanghai Zerun Biotechnology Co.,LtdINDUSTRY | 1 | Apr 13, 2023 | clinicaltrials |
| NCT03064087 | Validation of Human Papillomavirus Assays and Collection Devices for Self-samples and Urine Samples(VALHUDES) | active not recruiting | — | 500 | Marc ArbynOTHER_GOV | 1 | Mar 29, 2023 | clinicaltrials |
| NCT04704908 | Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m) | unknown | — | 979 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT04969445 | The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female | unknown | — | 647 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05045755 | The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female | unknown | — | 1,339 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT04191967 | Thermocoagulation for Treatment of Precancerous Cervical Lesions | completed | N/A | 379 | University of California, San FranciscoOTHER | 1 | Jan 25, 2023 | clinicaltrials |
| NCT04312737 | Evaluation of in Vitro Devices on Self-collected Vaginal Swab and Urine Sample for Testing of Human Papilloma Virus(EU-VALHUDES) | completed | — | 600 | Hiantis SrlINDUSTRY | 3 | Jan 6, 2023 | clinicaltrials |
| NCT02733068 | A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine. | completed | Phase 3 | 12,000 | Shanghai Zerun Biotechnology Co.,LtdINDUSTRY | 0 | Dec 19, 2022 | clinicaltrials |
| NCT03049553 | Trial23 - A Method Study on Cervical Screening in Women Offered HPV-vaccination as Girls | unknown | N/A | 7,000 | University of CopenhagenOTHER | 1 | Nov 4, 2022 | clinicaltrials |
| NCT05580341 | Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9 | unknown | Phase 3 | 1,200 | Shanghai Zerun Biotechnology Co.,LtdINDUSTRY | 1 | Oct 28, 2022 | clinicaltrials |
| NCT05595252 | Retrospective Study on the Evolution of CIN 1 to 3 in Per and Postpartum in Nancy From 2014 to 2022 | unknown | — | 100 | Central Hospital, Nancy, FranceOTHER | 1 | Oct 26, 2022 | clinicaltrials |
| NCT05536843 | Clinical, Translational and Biomarker-Based Female Genital HPV Induced Dysplasia and Cancer Screening Study Using Cf-HPV-DNA Blood Tests(TTMV HPV DNA) | unknown | — | 500 | University of Mississippi Medical CenterOTHER | 0 | Sep 13, 2022 | clinicaltrials |
| NCT05510830 | Diagnostic Cervical Conization for Persistent Infection or Integration of HPV | not yet recruiting | N/A | 250 | Tongji HospitalOTHER | 1 | Sep 8, 2022 | clinicaltrials |
| NCT05142397 | The Dynamic Process of VMB and Mucosal Immunity After FUS Treatment of CIN Patients With Fertility Requirement | unknown | — | 90 | Shufang ChangOTHER | 1 | Aug 18, 2022 | clinicaltrials |
| NCT04484415 | Efficacy and Safety of Cevira® in Patients With Cervical Histologic High-grade Squamous Intraepithelial Lesions (HSIL)(APRICITY) | unknown | Phase 3 | 402 | Asieris MediTech (Hong Kong) Co., Ltd.INDUSTRY | 1 | Aug 12, 2022 | clinicaltrials |
| NCT04326049 | LLETZ With Videocolposcopy Versus LLETZ With Binocular Colposcopy | completed | N/A | 227 | Zydolab - Institute of Cytology and Immune CytochemistryOTHER | 1 | Jul 19, 2022 | clinicaltrials |
| NCT04415840 | Lugol's Solution in Addition to Acetic Acid During Colposcopy | completed | — | 323 | Zydolab - Institute of Cytology and Immune CytochemistryOTHER | 1 | Jul 19, 2022 | clinicaltrials |
| NCT02529930 | An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3) | completed | Phase 1 / Phase 2 | 34 | Nykode Therapeutics ASAINDUSTRY | 1 | Jul 13, 2022 | clinicaltrials |
| NCT02330471 | Forced Versus Spray Coagulation in Women Undergoing LLETZ-conization for Cervical Dysplasia: a Randomized Trial(CONE-1) | completed | Phase 3 | 160 | Ruhr University of BochumOTHER | 1 | Jul 8, 2022 | clinicaltrials |
| NCT02476500 | Construct Validity of a Large Loop Excision of the Transformation Zone (LLETZ) Training Model(LLETZ-1) | completed | N/A | 150 | Ruhr University of BochumOTHER | 1 | Jul 8, 2022 | clinicaltrials |
| NCT05426148 | Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female | completed | Phase 4 | 540 | Xiamen Innovax Biotech Co., LtdINDUSTRY | 1 | Jun 29, 2022 | clinicaltrials |
| NCT04530201 | CASUS: Validation for Detection of Precursor Lesions(CASUS-WP4) | completed | N/A | 332 | Universiteit AntwerpenOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT04742543 | Virtual Reality During Conization of Cervix Uterus Under Local Anesthesia | unknown | N/A | 100 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Jun 2, 2022 | clinicaltrials |
| NCT04298957 | See and Treat in an Outpatient Setting in Women Above 45 Years With Cervical Dysplasia | completed | N/A | 109 | University of AarhusOTHER | 1 | May 18, 2022 | clinicaltrials |
| NCT05309122 | Cervical Cancer Screening Strategies | unknown | — | 10,000 | Lei LiOTHER | 1 | Apr 4, 2022 | clinicaltrials |
| NCT05290428 | DNA PAX1 and JAM3 Methylation for Cervical Cancer Screening | unknown | — | 459 | Peking Union Medical College HospitalOTHER | 1 | Mar 22, 2022 | clinicaltrials |
| NCT05225493 | HIV Indicator Diseases in Hospital and Primary Care(#AwareHIV) | unknown | — | 1,500 | Erasmus Medical CenterOTHER | 1 | Feb 4, 2022 | clinicaltrials |
Data updated 23 days agoSource updated May 16, 2024source: clinicaltrials